Robert Peach
Förmögenhet: 464 227 $ per 2026-08-31
Förmögenhet: 464 227 $ per 2026-08-31
Robert J.
Peach was the founder of Apoptos, Inc. (2007) as Vice President-Biology and Receptos LLC (2009) as Chief Scientific Officer.
Dr. Peach is currently an Independent Non-Executive Director at Amplia Therapeutics Ltd. since 2015.
Former positions include Senior Director-Oncology Discovery at Biogen, Inc. (2005-2007), Director at Avalia Immunotherapies Ltd., Independent Non-Executive Director at AdAlta Ltd. (2016-2024), and Principal at Bristol Myers Squibb Co. (1991-2000).
Education includes a doctorate from the University of Otago and undergraduate and graduate degrees from the University of Canterbury.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
AMPLIA THERAPEUTICS LTD. 0,93 % | 2025-09-06 | 4 798 212 ( 0,93 % ) | 464 227 $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| AMPLIA THERAPEUTICS LIMITED | Direktör/Styrelseledamot | 2015-09-02 |
| Företag | Position | Slut |
|---|---|---|
| ADALTA LIMITED | Direktör/Styrelseledamot | 2024-11-20 |
| RECEPTOS INC | Grundare | 2015-08-27 |
Apoptos, Inc.
Apoptos, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule anticancer drugs | Grundare | 2009-05-01 |
| BIOGEN INC. | Företagsledare/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 9 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Apoptos, Inc.
Apoptos, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule anticancer drugs | Health Technology |
Receptos LLC
Receptos LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapeutics in immune disease | Health Technology |
University of Otago
University of Otago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Canterbury
University of Canterbury Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AdAlta Ltd.
AdAlta Ltd. BiotechnologyHealth Technology Discovers and develops i-body drugs to treat fibrotic diseases | Health Technology |
Amplia Therapeutics Ltd.
Amplia Therapeutics Ltd. BiotechnologyHealth Technology Develops drug candidates for oncology and chronic fibrosis | Health Technology |
Avalia Immunotherapies Ltd.
Avalia Immunotherapies Ltd. Medical/Nursing ServicesHealth Services Engages in developing immunotherapy’s that support the treatment of cancer and other diseases | Health Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån